NEW YORK (GenomeWeb News) — Qiagen and Exosome Diagnostics said today that they have expanded their collaboration to develop non-invasive in vitro molecular diagnostics.

The diagnostics will be based on Exosome's proprietary methods for purifying nucleic acids from biofluid exosomes and other microvesicles with Qiagen's sample prep technologies to create "cost-effective, easy-to-use, and automated sample-to-results workflows," the companies said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: spatiotemporal study of lncRNA expression, role of extrachromosomal, circular DNAs in yeast, and more.

A European team has launched a four-year study to develop a test to gauge cervical, ovarian, uterine, or aggressive breast cancer risk in women.

As interest in personalized medicine grows, government contractors are entering the field, the Washington Post reports.

In PLOS this week: Plasmodium knowlesi population genetics, oral microbiome of infants and children, and more.